CMBA
QGENF

C.M. Bidwell & Associates’s QIAGEN NV QGENF Stock Holding History

C.M. Bidwell & Associates’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-144,340
Closed -$3.96M – 349
2016
Q3 		$3.96M Buy
+144,340
New +$3.96M 0.94% 46

Other funds holding QGENF

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

C.M. Bidwell & Associates's QGENF Position: Q4 2016 in Review

C.M. Bidwell & Associates sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 144,340 shares — an estimated $3.96M sold.

C.M. Bidwell & Associates first reported a position in QGENF in Q3 2016 and held it in 1 quarter. The position peaked at $3.96M in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • C.M. Bidwell & Associates reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 144,340 QIAGEN NV shares in Q4 2016, an estimated $3.96M.
  • C.M. Bidwell & Associates first reported a position in QIAGEN NV in Q3 2016 and held it in 1 quarter.
  • C.M. Bidwell & Associates's QIAGEN NV position peaked at $3.96M in Q3 2016.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2016, filed 13 Feb 2017.